SN BioScience
- Biotech or pharma, therapeutic R&D
CLINICAL-STAGE drug development company with innovative drug delivery system targeting ONCOLOGY and METABOLIC(anti-obesity) disease with low development risk and accelerated commercialization potential
SNB-101: WW Market entry in 2028 (SCLC)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}